Treatment plan—Subacute pain.
(1) The osteopathic physician shall recognize the progression of a patient from the acute nonoperative or acute perioperative phase to the subacute phase and take into consideration the risks and benefits of continued opioid prescribing for the patient.
(2) If tapering has not begun prior to the six- to twelve-week subacute phase, the osteopathic physician shall reevaluate the patient who does not follow the expected course of recovery. If significant and documented improvement in function or pain control has not occurred, the osteopathic physician shall reconsider the continued use of opioids or whether tapering or discontinuing opioids is clinically indicated. The osteopathic physician shall make reasonable attempts to discontinue the use of opioids prescribed for the acute pain event by no later than the twelve-week conclusion of the subacute phase.
(3) If the osteopathic physician prescribes opioids for effective pain control, such prescription must not be in a greater quantity than needed for the expected duration of pain severe enough to require opioids. The osteopathic physician shall not prescribe beyond a fourteen-day supply of opioids without clinical documentation to justify the need for such a quantity during the subacute phase.
(4) If the osteopathic physician elects to prescribe a combination of opioids with a medication listed in WAC
246-853-775 or prescribes opioids to a patient known to be receiving a medication listed in WAC
246-853-775 from another practitioner, the osteopathic physician shall prescribe in accordance with WAC
246-853-775.
(5) If the osteopathic physician elects to treat a patient with opioids beyond the six- to twelve-week subacute phase, the osteopathic physician shall document in the patient record that the patient is transitioning from subacute pain to chronic pain. Rules governing the treatment of chronic pain in WAC
246-853-715 through
246-853-760 shall apply.
[Statutory Authority: RCW
18.57.800,
18.57A.800 and 2017 c 297. WSR 18-20-087, § 246-853-710, filed 10/1/18, effective 11/1/18.]